SEARCH

SEARCH BY CITATION

References

  • 1
    Seeger C, Mason WS. Hepatitis B virus biology. Microbiol Mol Biol Rev 2000; 64: 5168.
  • 2
    Nassal M, Schaller H. Hepatitis B virus replication. Trends Microbiol 1993; 1: 2218.
  • 3
    Arbuthnot P, Kew M. Hepatitis B virus and hepatocellular carcinoma. Int J Exp Pathol 2001; 82: 77100.
  • 4
    Murakami S. Hepatitis B virus X protein: structure, function and biology. Intervirology 1999; 42: 8199.
  • 5
    Murakami S. Hepatitis B virus X protein: a multifunctional viral regulator. J Gastroenterol 2001; 36: 65160.
  • 6
    Murakami S, Cheong JH, Kaneko S. Human hepatitis virus X gene encodes a regulatory domain that represses transactivation of X protein. J Biol Chem 1994; 269: 15 11823.
  • 7
    Lin Y, Tang H, Nomura T et al . The hepatitis B virus X protein is a co-activator of activated transcription that modulates the transcription machinery and distal binding activators. J Biol Chem 1998; 273: 27 097103.
  • 8
    Tang H, Delgermaa L, Huang F et al . The transcriptional transactivation function of HBx protein is important for its augmentation role in hepatitis B virus replication. J Virol 2005; 79: 554856.
  • 9
    Shirakata Y, Kawada M, Fujiki Y et al . The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH3T3 cells. Jpn J Cancer Res 1989; 80: 61721.
  • 10
    Kim YC, Song KS, Yoon G et al . Activated ras oncogene collaborates with HBx gene of hepatitis B virus to transform cells by suppressing HBx-mediated apoptosis. Oncogene 2001; 20: 1623.
  • 11
    Kim CM, Koike K, Saito I, Miyamura T, Jay G. HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 1991; 351: 31720.
  • 12
    Yu DY, Moon HB, Son JK et al . Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein. J Hepatol 1999; 31: 12332.
  • 13
    Gottlob K, Pagano S, Levrero M, Graessmann A. Hepatitis B virus X protein transcription activation domains are neither required nor sufficient for cell transformation. Cancer Res 1998; 58: 356670.
  • 14
    Slagle BL, Lee TH, Medina D, Finegold MJ, Butel JS. Increased sensitivity to the hepatocarcinogen diethylnitrosamine in transgenic mice carrying the hepatitis B virus X gene. Mol Carcinog 1996; 15: 2619.
  • 15
    Terradillos O, Billet O, Renard CA et al . The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice. Oncogene 1997; 14: 395404.
  • 16
    Artandi SE, DePinho RA. Mice without telomerase: what can they teach us about human cancer? Nat Med 2000; 6: 8525.
  • 17
    Balmain A, Harris CC. Carcinogenesis in mouse and human cells: parallels and paradoxes. Carcinogenesis 2000; 21: 3717.
  • 18
    Rangarajan A, Hong SJ, Gifford A, Weinberg RA. Species- and cell type-specific requirements for cellular transformation. Cancer Cell 2004; 6: 17183.
  • 19
    Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA. Creation of human tumour cells with defined genetic elements. Nature 1999; 400: 4648.
  • 20
    Wei W, Jobling WA, Chen W, Hahn WC, Sedivy JM. Abolition of cyclin-dependent kinase inhibitor p16Ink4a and p21Cip1/Waf1 functions permits Ras-induced anchorage-independent growth in telomerase-immortalized human fibroblasts. Mol Cell Biol 2003; 23: 285970.
  • 21
    Akagi T, Sasai K, Hanafusa H. Refractory nature of normal human diploid fibroblasts with respect to oncogene-mediated transformation. Proc Natl Acad Sci USA 2003; 100: 13 56772.
  • 22
    Greenberg RA, Allsopp RC, Chin L, Morin GB, DePinho RA. Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation. Oncogene 1998; 16: 172330.
  • 23
    Newbold RF. Genetic control of telomerase and replicative senescence in human and rodent cells. Ciba Found Symp 1997; 211: 17789.
  • 24
    Harvey M, Sands AT, Weiss RS. et al . In vitro growth characteristics of embryo fibroblasts isolated from p53-deficient mice. Oncogene 1993; 8: 245767.
  • 25
    Kamijo T, Zindy F, Roussel MF. et al . Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 1997; 91: 64959.
  • 26
    Sedivy JM. Can ends justify the means? Telomeres and the mechanisms of replicative senescence and immortalization in mammalian cells. Proc Natl Acad Sci USA 1998; 95: 907881.
  • 27
    Shay JW, Wright WE, Werbin H. Defining the molecular mechanisms of human cell immortalization. Biochim Biophys Acta 1991; 1072: 17.
  • 28
    Bodnar AG, Ouellette M, Frolkis M et al . Extension of life-span by introduction of telomerase into normal human cells. Science 1998; 279: 34952.
  • 29
    Halvorsen TL, Leibowitz G, Levine F. Telomerase activity is sufficient to allow transformed cells to escape from crisis. Mol Cell Biol 1999; 19: 186470.
  • 30
    Hahn WC. Role of telomeres and telomerase in the pathogenesis of human cancer. J Clin Oncol 2003; 21: 203443.
  • 31
    Sharpless NE, DePinho RA. Cancer: crime and punishment. Nature 2005; 436: 6367.
  • 32
    Braig M, Lee S, Loddenkemper C et al . Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 2005; 436: 6605.
  • 33
    Hahn WC, Dessain SK, Brooks MW et al . Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol 2002; 22: 211123.
  • 34
    Tang H, Oishi N, Kaneko S, Murakami S. Molecular functions and biological roles of hepatitis B virus X protein. Cancer Sci 2006; 97: 97783.
  • 35
    Pang R, Lee TK, Poon RT et al . Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis. Gastroenterology 2007; 132: 10881103.
  • 36
    Elmore LW, Hancock AR, Chang SF et al . Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis. Proc Natl Acad Sci USA 1997; 94: 14 70712.
  • 37
    Lin Y, Nomura T, Yamashita T, Dorjsuren D, Tang H, Murakami S. The transactivation and p53-interacting functions of hepatitis B virus X protein are mutually interfering but distinct. Cancer Res 1997; 57: 513742.
  • 38
    Lee DK, Park SH, Yi Y et al . The hepatitis B virus encoded oncoprotein pX amplifies TGF-beta family signaling through direct interaction with Smad4: potential mechanism of hepatitis B virus-induced liver fibrosis. Genes Dev 2001; 15: 45566.
  • 39
    Lee TH, Elledge SJ, Butel JS. Hepatitis B virus X protein interacts with a probable cellular DNA repair protein. J Virol 1995; 69: 110714.
  • 40
    Leupin O, Bontron S, Schaeffer C, Strubin M. Hepatitis B virus X protein stimulates viral genome replication via a DDB1-dependent pathway distinct from that leading to cell death. J Virol 2005; 79: 423845.
  • 41
    DePinho RA. The age of cancer. Nature 2000; 408: 24854.
  • 42
    Kobayashi N, Noguchi H, Watanabe T et al . A new approach to develop a biohybrid artificial liver using a tightly regulated human hepatocyte cell line. Hum Cell 2000; 13: 22935.
  • 43
    Kobayashi N, Miyazaki M, Fukaya K et al . Treatment of surgically induced acute liver failure with transplantation of highly differentiated immortalized human hepatocytes. Cell Transplant 2000; 9: 7335.